NCT07587216 Prospective Clinical Database Construction for Liver Cancer Diagnosis and Treatment
| NCT ID | NCT07587216 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tongji Hospital |
| Condition | Liver Cancer (Primary and Metastatic) |
| Study Type | OBSERVATIONAL |
| Enrollment | 800 participants |
| Start Date | 2026-01-01 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 800 participants in total. It began in 2026-01-01 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is a prospective, observational, real-world cohort study. We aim to establish a prospective database in the Department of Hepatobiliary and Pancreatic Surgery, systematically collecting and integrating patients' full-course diagnostic and therapeutic information along with long-term outcomes. This will enable objective evaluation of prognosis and treatment efficacy in real-world clinical practice, while providing a data foundation and evidence support for subsequent optimization of clinical decision-makin
Eligibility Criteria
Inclusion Criteria: * Male or female aged ≥18 years at the time of signing the informed consent form * Clinically or histologically confirmed diagnosis of liver cancer * Recieving treatment and follow-up in Tongji Hospital Exclusion Criteria: \- Refuse participanting in this study
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07587216 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Liver Cancer (Primary and Metastatic). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07587216 currently recruiting?
Yes, NCT07587216 is actively recruiting participants. Contact the research team at chengqi@hust.edu.cn for enrollment information.
Where is the NCT07587216 trial being conducted?
This trial is being conducted at Wuhan, China.
Who is sponsoring the NCT07587216 clinical trial?
NCT07587216 is sponsored by Tongji Hospital. The trial plans to enroll 800 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.